MTERF1通过AMPK/mTOR通路调节糖尿病脏病中的足细胞线粒体DNA复制障碍和线粒体功能障碍
1Department of Endocrinology, Taizhou First People's Hospital, Taizhou, Zhejiang, China.
Annals of clinical and laboratory science
|November 18, 2025
概括
线粒体转录终止因子1 (MTERF1) 在糖尿病病中保护细胞免受高葡萄糖损伤. 过度表达MTERF1激活AMPK/mTOR通路,改善线粒体功能和DNA复制.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 糖尿病脏病 (DN) 涉及皮质细胞损伤和线粒体功能障碍.
- 线粒体转录终结因子1 (MTERF1) 在线粒体DNA (mtDNA) 调节中起作用.
- 在DN podocytes中MTERF1的确切机制尚不清楚.
研究的目的:
- 阐明MTERF1在调节mtDNA复制和糖尿病脏病中 podocyte 线粒体功能的作用.
- 研究涉及AMPK/mTOR信号通路的潜在分子机制.
主要方法:
- 已建立的链毒素诱导型I型糖尿病小鼠模型和高葡萄糖 (HG) 治疗的MPC-5 podocyte细胞模型.
- 在体内评估功能,球损伤和MTERF1表达.
- 量化细胞亡,活力,mtDNA拷贝数,ATP生产,线粒体活性氧物种 (mtROS) 和线粒体膜潜力 (MMP) 在体外.
- 利用MTERF1过度表达细胞和AMPK抑制剂 (化合物C) 来探索通路激活.
主要成果:
- DN小鼠表现出高血糖,功能障碍,球膜损伤和MTERF1表达的降低.
- 用HG治疗的细胞表现出亡的增加,活力的降低,MTERF1,mtDNA拷贝数和ATP水平的降低.
- 在HG podocytes中MTERF1过度表达恢复了mtDNA复制,ATP生产,线粒体膜潜力,并激活了AMPK/mTOR通路,同时减少了mtROS.
- 抑制AMPK/mTOR信号反转了MTERF1.1的保护作用.
结论:
- 过度表达MTERF1通过增强mtDNA复制和线粒体功能来减轻高葡萄糖诱导的细胞损伤.
- 激活AMPK/mTOR信号通路对于MTERF1在糖尿病病中的保护作用至关重要.
- MTERF1代表了改善DNA中线粒体健康的潜在治疗标.
更多相关视频
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
586
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
12.2K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
ATP Synthase: Mechanism
16.6K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
16.6K
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
